Table 1 Summary of baseline characteristics in no recurrence group and recurrence group in 143 patients with CSDH
Factor | No recurrence (%) | Recurrence (%) | p value |
|---|---|---|---|
Total | 136 (95.1%) | 7 (4.9%) | |
Sex | 0.231 | ||
Female | 34 (23.8%) | 0 (0.0%) | |
Male | 102 (71.2%) | 7 (4.9%) | |
Age (years) | 70.75 ± 8.91 | 64.14 ± 15.52 | 0.418 |
Diabetes | 22 (15.4%) | 2 (1.4%) | 0.736 |
Hypertension | 60 (41.9%) | 1 (0.7%) | 0.244 |
Antiplatelet and/or anticoagulant use | 16 (11.2%) | 1 (0.7%) | 0.436 |
Bilateral hematoma | 16 (11.2%) | 0 (0.0%) | 1.000 |
History of trauma | 73 (51.0%) | 3 (2.1%) | 0.949 |
Brain atrophy | 0.758 | ||
Mild | 102 (71.3%) | 5 (3.5%) | |
Moderate | 26 (18.2%) | 2 (1.4%) | |
Severe | 8 (5.6%) | 0 (0%) | |
Hematoma thickness (cm) | 1.97 ± 0.56 | 2.13 ± 0.52 | 0.482 |
Midline shift (cm) | 0.86 ± 0.55 | 0.69 ± 0.51 | 0.426 |
Density of hematoma on CT | ≺ 0.001 | ||
Isodensity hematoma | 64 (44.8%) | 0 (0%) | |
Low-density hematoma | 26 (18.2%) | 0 (0%) | |
High-density hematoma | 23 (16.1%) | 1 (0.7%) | |
Mixed density hematoma | 23 (16.1%) | 6 (4.2%) | |
Neomembrane in CT | 13 (9.1%) | 4 (2.8%) | 0.003 |
Hematoma cavity separation in CT | 11 (7.7%) | 4 (2.8%) | 0.002 |
Hematoma cavity separation or Neomembrane in endoscopy | 34 (23.8%) | 6 (4.2%) | 0.001 |